- A New Frontier for Convergence in Gastroenterology and Hepatology
Nov. 28(Thu) |
Unveiling the road to early diagnosis of panceatic cancer | Convention Hall C (4F) |
Chair(s) | Dong Ki Lee (Korea), Tooru Shimosegawa (Japan) | |
08:45-09:10 | Genetic evolution from PanIN to pancreatic cancer | Kee-Taek Jang (Korea) |
09:10-09:35 | Challenge to screen early pancreatic cancer in general population | Keiji Hanada (Japan) |
09:35-10:05 | Genetic predisposition to pancreatic cancer, results from genome-wide association studies (GWAS) | Laufey Amundadottir (USA) |
10:05-10:30 | How to diagnose early pancreatic cancer: from Japanese experiences | Tooru Shimosegawa (Japan) |
Nov. 28(Thu) 09:00-10:30 |
Noticeable research of liver disease in year 2019 | Convention Hall A+B (4F) |
Chair(s) | Jung-Hwan Yoon (Korea), Kwan Soo Byun (Korea) | |
09:00-09:22 | Viral hepatitis | Hyung Joon Yim (Korea) |
09:22-09:44 | Alcohol-related and non-alcoholic fatty liver diseases | Yong Kyun Cho (Korea) |
09:44-10:06 | Liver cirrhosis and complications | Moon Young Kim (Korea) |
10:06-10:28 | Hepatocellular carcinoma | Ju Hyun Shim (Korea) |
Nov. 28(Thu) 09:00-10:30 |
A to Z of Functional Dyspepsia | Emerald Hall A (3F) |
Chair(s) | Sei Jin Youn (Korea), Oh Young Lee (Korea) | |
09:00-09:22 | Pathophysiology | Chung Hyun Tae (Korea) |
09:22-09:44 | Assessment | Jong Kyu Park (Korea) |
09:44-10:06 | Pharmacological therapy | Jung Hwan Oh (Korea) |
10:06-10:28 | Non-pharmacological therapy | Kyoungwon Jung (Korea) |
Nov. 28(Thu) 09:00-10:30 |
Plenary Session | Emerald Hall B (3F) |
Chair(s) | Jae Gyu Kim (Korea), Chang-Hun Yang (Korea), Hyojin Park (Korea) | |
09:00-09:15 | Eradication of Helicobacter Pylori infection Decreases Risk for Dyslipidemia: A Cohort Study | Yewan Park (Korea) |
09:15-09:30 | Clinical Epidemiology of Esophageal Cancer during Recent 10 years: Nationwide Cohort Study of 6354 Patients with Esophageal Cancer in Korea | Hye-Kyung Jung (Korea) |
09:30-09:45 | Exogenous Vasoactive Intestinal Peptide Maintains Colon Mucosal Lining in Experimental Colitis Models by Attenuating Colonic Mitochondrial Dysfunction through Scavenging of Superoxide and Hydroxyl Radicals: Implications in Ulcerative Colitis | Arpan Maiti (India) |
09:45-10:00 | Low skeletal muscle mass is an independent risk factor for advanced colorectal neoplasm: Integrative analysis using three skeletal muscle mass indices | Hyo Jeong Lee (Korea) |
10:00-10:15 | The effect of bile acid as a major regulator of intestinal microbiotia, Especially on different parts of the mice colon | Mingyu Seok (Korea) |
10:15-10:30 | Lyon Gastro-esophageal Reflux Disease Consensus Criteria is not correlated with Gastroesophageal Reflux Disease Questionnaire in Korean Patients | Hyungchul Park (Korea) |
Nov. 28(Thu) 09:00-10:30 |
Beyond big data to artificial intelligence(AI) in colon cancer | Diamond Hall (3F) |
Chair(s) | Ming-Shiang Wu (Taiwan), Hyun-Soo Kim (Korea) | |
09:00-09:22 | Population-based tailored approach by age and sex dependent cutoffs of FIT | Chang Mo Moon (Korea) |
09:22-09:44 | Big data driven economical appraisal for colorectal cancer screening program | Ming-Fang Yen (Taiwan) |
09:44-10:06 | AI image classifier for the prediction of histology and endoscopic resectability | Wai Keung Leung (Hong Kong) |
10:06-10:28 | Deep learning based treatment decision for T1 cancer; endoscopy vs. surgery | Katsuro Ichimasa (Japan) |
Nov. 28(Thu) |
Special Lecture | Grand Ballroom B, C (Main 2F) |
Chair(s) | Hyunyong Jeong (Korea) | |
09:40-10:20 | Development of Effective Immune Checkpoint Cancer Therapy | Mien-Chie Hung (Taiwan) |
Nov. 28(Thu) |
Presidential Lecture - Chung Yong Kim Memorial Lecture | Convention Hall A+B (4F) |
Chair(s) | Kwan Sik Lee (Korea) | |
11:00-11:30 | Alcoholic Liver Disease -Past, Present, and Future | Dong Joon Kim (Korea) |
Nov. 28(Thu) 11:00-12:30 |
Current status and perspective for early diagnosis of pancreatic cancer | Convention Hall C (4F) |
Chair(s) | Laufey Amundadottir (USA), Yong-Tae Kim (Korea) | |
11:00-11:25 | Protein science; liquid-chromatography-tandem mass spectrometry : Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in biology of Pancreatic ductal adenocarcinoma | Kwang Pyo Kim (Korea) |
11:25-11:45 | Circulating tumor DNA and cells for pancreatic cancer | Dong-Uk Kim (Korea) |
11:45-12:05 | Pancreatic cancer specific immunological marker: Paradigm shifting in combating with Pancreatic cancer | Dong Ki Lee (Korea) |
12:05-12:30 | Exosome in pancreatic cancer surveillance | Takahiro Ochiya (Korea) |
Nov. 28(Thu) 11:00-12:30 |
Clinical problems overlooked in patients with GI cancer | Emerald Hall A (3F) |
Chair(s) | Geun Am Song (Korea), Kwang Ro Joo (Korea) | |
11:00-11:22 | Screening and management for High risk patients | Yun Jeong Lim (Korea) |
11:22-11:44 | Nutitional support guideline | Min Kyu Jung (Korea) |
11:44-12:06 | Cancer survivorship supporting program | Ji Soo Park (Korea) |
12:06-12:28 | Now and future direction of hospice and palliative care | Chung-woo Lee (Korea) |
Nov. 28(Thu) 11:00-12:30 |
Updates in GERD | Emerald Hall B (3F) |
Chair(s) | Sung Pyo Hong (Korea), Suck Chei Choi (Korea) | |
11:00-11:22 | Novel new options in the medical management of GERD | Nayoung Kim (Korea) |
11:22-11:44 | Usefulness of esophageal impedance measurement in diagnosis of GERD | Daniel Sifrim (UK) |
11:44-12:06 | The Lyon Consensus; how is it differ from previous ones? | Edoardo Savarino (Italy) |
12:06-12:28 | Current status of endoscopic management in GERD | Yuto Shimamura (Japan) |
Nov. 28(Thu) 11:00-12:30 |
Understanding of Eosinophilic Esophagitis | Diamond Hall (3F) |
Chair(s) | Soo-Heon Park (Korea), Jung Mogg Kim (Korea) | |
11:00-11:22 | Eosinophils in gastrointestinal tract | YunJae Jung (Korea) |
11:22-11:44 | Pathophysiology of food allergy and eosinophilic esophagitis | Young-Min Ye (Korea) |
11:44-12:06 | Updated diagnostic guideline and pharmacologic treatment | Da Hyun Jung (Korea) |
12:06-12:28 | Eosinophilic esophagitis in pediatrics and dietary treatment | Kunsong Lee (Korea) |
Nov. 28(Thu) 11:00-12:30 |
Grand Ballroom A (Main 2F) | |
Chair(s) | Soo Teik Lee (Korea), Dae Young Cheung (Korea) | |
11:00-11:10 | Current status gastric cancer among mongolian population | Tulgaa Lonjid (Mongolia) |
11:10-11:20 | Gender-specific Effect of dietary and physical activity on gastric cancer : population-based cohort study | Su Youn Nam (Korea) |
11:20-11:30 | Predictors of smoking cessation after diagnosis of cancer among gastrointestinal cancer survivors: Nationwide population based study | Youn I Choi (Korea) |
11:30-11:40 | Metformin decreases stomach cancer risk; comparing with other hypoglycemic agents | Hyeon Seok Lee (Korea) |
11:40-11:50 | Predictive factors for extragastric recurrence of early gastric cancer after curative resection | Young Min Kim (Korea) |
11:50-12:05 | Topic forum | Dae Young Cheung (Korea) |
Nov. 28(Thu) |
Clinical application of gender medicine: from research to bedside | Grand Ballroom B, C (Main 2F) |
Chair(s) | Etsuko Hashimoto (Japan), Seunja Park (Korea) | |
11:00-11:15 | Is it important to know gender difference for FGID patients? | Hidekazu Suzuki (Japan) |
11:15-11:30 | Gender difference in gastric cancer | Mei-Jyh Chen (Taiwan) |
11:30-11:45 | Different approach to treat liver disease by gender difference | Jung Il Lee (Korea) |
11:45-11:50 | Discussion |
Nov. 28(Thu) |
Development of career promotion program for women and young doctors | Grand Ballroom B, C (Main 2F) |
Chair(s) | Hidekazu Suzuki (Japan), Nayoung Kim (Korea) | |
12:00-12:05 | Japan experience | Etsuko Hashimoto (Japan) |
12:05-12:10 | Korean experience | Seon Mee Park (Korea) |
12:10-12:15 | Taiwan experience | Mei-Jyh Chen (Taiwan) |
12:15-12:30 | Discussion |
Nov. 28(Thu) |
Flamingo (Main 2F) | |
Chair(s) | Dae Hwan Kang (Korea), Byoung Kwan Son (Korea) | |
11:00-11:08 | Litholytic agents as an alternative treatment modality in patients with biliary dyspepsia | Young Min Kim (Korea) |
11:08-11:16 | AGT score as a predictor of common bile duct stone using endoscopic ultrasound (EUS) in patients with intermediate probability criteria according to ASGE guidelines | Muhammad Manzoor Ul Haq (Pakistan) |
11:16-11:24 | Changes of bacteriobilia and clinical outcome in patients with biliary infection | Jai Hoon Yoon (Korea) |
11:24-11:32 | Benefits and pitfalls of surgical resection after downstaging concurrent chemoradiation therapy in patients with locally advanced perihilar cholangiocarcinoma | Incheon Kang (Korea) |
11:32-11:40 | Predictive biomarkers in the gemcitabine plus cisplatin for unresectable or recurrent biliary tract cancer: a single-center, prospective study | Boyoung Lee (Korea) |
Nov. 28(Thu) |
Flamingo (Main 2F) | |
Chair(s) | Eun Kwang Choi (Korea), Dong Kee Jang (Korea) | |
11:40-11:48 | High PD-L1 expression is associated with response to pembrolizumab in patients with advanced biliary tract cancer | Dong Woo Shin (Korea) |
11:48-11:56 | Efficacy and safety of Pembrolizumab for gemcitabine/cisplatin-refractory biliary tract cancer: multicenter retrospective study | Sang Hoon Lee (Korea) |
11:56-12:04 | Survival improvement and prognostic factors in recent management of extrahepatic cholangiocarcinoma | Hyo Jung Kim (Korea) |
12:04-12:12 | Which is the determining factor for selection of the antimicrobial agent in patient with acute cholangitis, bile or blood? | HyoJin Kwon (Korea) |
12:04-12:20 | Side-by-Side Simultaneous Insertion of Covered Metal Stent and Plastic Stent for Malignant Biliary Obstruction: A Pilot Study for Efficacy, Patency and Safety | Jae Ok Park (Korea) |
Nov. 28(Thu) |
Skylark (Main 2F) | |
Chair(s) | Byung Ik Jang (Korea), Hyun Jung Lee (Korea) | |
11:00-11:08 | Comparison of conventional and modified endoscopic mucosal resections for the treatment of rectal neuroendocrine tumors | Hee Sung Lee (Korea) |
11:08-11:16 | Patterns of seroid use in Korean patients with inflammatory bowel disease | Yehyun Park (Korea) |
11:16-11:24 | Comparison of bowel-cleansing efficacy of spit-dose and same-day dose bowel preparation for afternoon colonoscopy in patients with gastrectomy: a prospective randomized study | Tae-Geun Gweon (Korea) |
11:24-11:32 | Characterization of Intestinal Microbic and Metabolic Microenvironment Signatures of Inflammatory Bowel Disease | Shengtao Zhu (China) |
11:32-11:40 | A Multicenter, Open-label, Controlled, Randomized Study Comparing 4g Once Daily with 2g Two Times Daily Prolonged-release Mesalamine for Mild to Moderate active Ulcerative Colitis | Kang-Moon Lee (Korea) |
Nov. 28(Thu) |
Skylark (Main 2F) | |
Chair(s) | Jong Pil Im (Korea), Sang-Bum Kang (Korea) | |
11:40-11:48 | Dipstick proteinuria predicts the development of Crohn's disease: a Nationwide Population-based Study | Seona Park (Korea) |
11:48-11:56 | Modified Enhanced Recovery after Surgery (mERAS) in colorectal surgery: Outcome of novel experience in colorectal surgery in a limited resource setting in South Asia | Chamila Lakmal (Sri Lanka) |
11:56-12:04 | Effect of Faecal Microbiota Transplantation on Clearance of Carbapenemase-producing Enterobacteraceae. | Boram CHA (Korea) |
12:04-12:12 | NUDT15 intermediate metabolizers are associated with longer infliximab durability in pediatric Crohn's disease patients treated by combination treatment with infliximab and azathioprine | Eun Sil Kim (Korea) |
Nov. 28(Thu) |
White Heron (Main 2F) | |
Chair(s) | Hyungkil Kim (Korea) | |
11:00-11:08 | OLGA and OLGIM stage for the prediction of metachronous gastric neoplasia after endoscopic resection in Helicobacter pylori negative early gastric cancer patients | Jun Hyuk Kang (Korea) |
11:08-11:16 | Pre-procedural features for predicting the risk of lymph node metastasis in early gastric cancer | Dong-Jun Kim (Korea) |
11:16-11:24 | Favorable Long-term Outcomes of Endoscopic Submucosal Dissection for Differentiated-type-Predominant Early Gastric Cancer with Histological Heterogeneity | Tae-Se Kim (Korea) |
11:24-11:32 | Development of Endoscopic Scoring System to Predict Risk of Intestinal type Gastric Cancer: Preliminary prospective study | Hee Kyong Na (Korea) |
11:32-11:40 | Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma | Ga Hee Kim (Korea) |
Nov. 28(Thu) |
White Heron (Main 2F) | |
Chair(s) | Byung-Wook Kim (Korea), Chan Gyoo Kim (Korea) | |
11:40-11:48 | Accuracy of Endoscopic Ultrasound (EUS) for superficial esophageal cancer and factors affecting overstaging. | Jinju Choi (Korea) |
11:48-11:56 | Clinical significance of simulation CT images during definitive chemoradiotherapy in locally advanced esophageal cancer | Jungi Yeom (Korea) |
11:56-12:04 | Comparison between gastrostomy and self-expandable metal stent for malignant esophageal obstruction, after propensity score matching | Joo Hye Song (Korea) |
12:04-12:12 | Clinical Outcomes of Mucinous Gastric Carcinomas Compared with Non-mucinous and Signet Ring Cell Carcinomas | Honggeun Ahn (Korea) |
12:12-12:20 | Mucosal transplantation for the management of stricture after endoscopic submucosal dissection | Saif Ullah (China) |
Nov. 28(Thu) 12:30-13:30 |
CHB Patients Today and Tomorrow: Journey toward optimal management for CHB patients | Convention Hall A+B (4F) |
Chair(s) | Seung Kew Yoon (Korea) | |
12:30-12:40 | CHB patients tomorrow: What we expect from treatment evolution in the near future? | Seung Kew Yoon (Korea) |
12:40-13:10 | CHB patients today: What we have to do now for CHB patients? | Tetsuya Hosaka (Japan) |
13:10-13:30 | Q&A, Discussion |
Nov. 28(Thu) 14:00-15:30 |
Modulation of gut-liver axis in liver diseases: How far have we come? | Convention Hall A+B (4F) |
Chair(s) | Jin Mo Yang (Korea), Kwang Cheol Koh (Korea) | |
14:00-14:20 | Serotonin signals through a gut-liver axis to regulate hepatic steatosis | Hail Kim (Korea) |
14:20-14:40 | Dysbiosis in patients with liver cirrhosis | Do Seon Song (Korea) |
14:40-15:00 | Gut microbiome and hepatocarcinogenesis | Su Jong Yu (Korea) |
15:00-15:20 | Modulation of gut-liver axis in liver diseases: How far have we come? | Ki Tae Suk (Korea) |
15:20-15:30 | Discussion |
Nov. 28(Thu) 14:00-15:30 |
Development of novel targets for pancreatic cancer | Convention Hall C (4F) |
Chair(s) | Si Young Song (Korea), Hong-Sik Lee (Korea) | |
14:00-14:30 | Cancer meet Microbiome and Immunology | Hansoo Park (Korea) |
14:30-15:00 | Tumor microenvironment as a therapeutic target for pancreatic cancer | Volker Ellenrieder (Germany) |
15:00-15:30 | Drug development with genomic big data and artificial intelligence for pancreatic cancer | Si Young Song (Korea) |
Nov. 28(Thu) 14:00-15:30 |
Update on diagnosis of small bowel disease: lessons from cases | Emerald Hall A (3F) |
Chair(s) | Hyun Soo Kim (Korea), Eun Young Kim (Korea) | |
14:00-14:22 | Capsule endoscopic findings of various small intestinal diseases | Hyun Joo Song (Korea) |
14:22-14:44 | Choice of small intestine imaging study: what and when? | Se Hyung Kim (Korea) |
14:44-15:06 | Diagnostic approach of suspected small bowel bleeding | Sung Hoon Jung (Korea) |
15:06-15:28 | Diagnostic approach of small bowel tumor | Seong-Ran Jeon (Korea) |
Nov. 28(Thu) |
Presidential Lecture | Emerald Hall B (3F) |
Chair(s) | Young Woo Kang (Korea) | |
14:00-14:40 | Pathogenesis and management of functional dyspepsia | Kwang Jae Lee (Korea) |
Nov. 28(Thu) |
Special Lecture | Emerald Hall B (3F) |
Chair(s) | Young Woo Kang (Korea), Kwang Jae Lee (Korea) | |
14:40-15:20 | Ineffective esophageal motility: from the Stanford 2018 symposium | Daniel Sifrim (UK) |
Nov. 28(Thu) |
Presidential Lecture | Diamond Hall (3F) |
Chair(s) | Jong-Jae Park (Korea) | |
14:00-14:40 | Extracellular vesicle in gastrointestinal disease and microbiome in gastric carcinogenesis | Jae Gyu Kim (Korea) |
Nov. 28(Thu) |
Special Lecture | Diamond Hall (3F) |
Chair(s) | Jae Gyu Kim (Korea) | |
14:40-15:20 | Personalized nutrition and gut microbiota | Ming-Shiang Wu (Taiwan) |
Nov. 28(Thu) 14:00-15:30 |
Grand Ballroom A (Main 2F) | |
Chair(s) | Ki Baik Hahm (Korea), Jae Jun Park (Korea) | |
14:00-14:10 | Classification of Esophageal Cancer Stadium using Recurrent Neural Network (RNN) Model | Rifaldy Fajar (Indonesia) |
14:10-14:20 | Quantitative analysis/Tissue Characterization for Malignant Mediastinal /Abdominal Lymph nodes using Endoscopic ultrasound Elastography EUS-EG | Kiran Bajaj (Pakistan) |
14:20-14:30 | Causal relationship between the loss of slc26a9 and gastric cancer | Dumin Yuan (China) |
14:30-14:40 | Additive tumor-suppressive effect of niclosamide and metformin in mouse model of colorectal cancer | Yoojeong Seo (Korea) |
14:40-14:50 | MiR-490-3p targets CDK1 through a phase-separation-depend system and inhibits the proliferation of colon cancer cells | Li Min (China) |
14:50-15:05 | Topic Forum | Jae Hyun Kim (Korea) |
Nov. 28(Thu) |
Flamingo (Main 2F) | |
Chair(s) | Jong Jin Hyun (Korea), Dong Wook Lee (Korea) | |
14:00-14:08 | Early Nasogastric tube feeding VS Nil per oral in mild to moderate Acute Pancreatitis | Akhilesh Kasyap (Korea) |
14:08-14:16 | Analysis of optimal procedure time to prevent post-ERCP pancreatitis using decision tree analysis: a retrospective single center analysis | Chang-Min Cho (Korea) |
14:16-14:24 | Incidence of pancreatic duct injury in pseudocyst and WON: a systematic review. | Yutthaya Ounklin (Thailand) |
14:24-14:32 | Prognostic value of the cytokine profile in diseases of the pancreas | Saidrakhim Nodirovich Lukmonov (Uzbekistan) |
14:32-14:40 | Response of pancreatic ductal adenocarcinoma to gemcitabine using human organotypic slice culture model | Jae Hyuck Chang (Korea) |
Nov. 28(Thu) |
E-poster Oral (PB2) | Flamingo (Main 2F) |
Chair(s) | Hyo Jung Kim (Korea), Jimin Han (Korea) | |
14:40-14:48 | EUS-guided pancreatic ductal adenocarcinoma organoid creation | Khanh Cong Pham (Thailand) |
14:48-14:56 | Correlation of clinical syndromes of chronic pancreatitis depending on the duration of the disease | Saidrakhim Lukmonov (Uzbekistan) |
14:56-15:04 | Antibiotics for mild to moderately severe acute pancreatitis with fever | Jin Myung Park (Korea) |
15:04-15:12 | Pancreatic duct stent without pancreatogram may reduce post-ERCP pancreatitis than pancreatic duct stent with pancreatogram | Jae Hyuck Jun (Korea) |
Nov. 28(Thu) |
Skylark (Main 2F) | |
Chair(s) | Hyungkil Kim (Korea), Chang-Kyun Lee (Korea) | |
14:00-14:08 | Clinical Characteristics of Campylobacter Enterocolitis in Korean adults: A retrospective study in a single center | Minseok Yoo (Korea) |
14:08-14:16 | TL1A affected epithelial-mesenchymal transition in intestinal mucosal epithelial cells of patients with IBD-related intestinal fibrosis | Wenxiu Jia (China) |
14:16-14:24 | Clinical significance of patch distribution of residual inflammation in UC patients with clinical remission. | Jongbeom Shin (Korea) |
14:24-14:32 | Clinical outcomes after discontinuation of anti-tumor necrosis factor- agents in inflammatory bowel disease patients with clinical remission: KASID multicenter study | Joo Hye Song (Korea) |
Nov. 28(Thu) |
Skylark (Main 2F) | |
Chair(s) | Jeong-Seon Ji (Korea), Won Moon (Korea) | |
14:32-14:40 | Red Rice Extract Ameliorates Inflammation in an Ulcerative Colitis Model | Napapan Kangwan (Thailand) |
14:40-14:48 | Allergic rhinitis induced colonic mucosal immune activation in murine model ; Association between Allergic rhinitis and Irritable bowel syndrome | Sang Hyun Kim (Korea) |
14:48-14:56 | ACTG2 gene mutation and clinical features in patients with chronic intestinal pseudo-obstruction | Jong Woo Hahn (Korea) |
Nov. 28(Thu) |
White Heron (Main 2F) | |
Chair(s) | Sung Kook Kim (Korea), Gwang Ho Baik (Korea) | |
14:00-14:08 | H.PYLORI PREVALENCE IN MONGOLIA BY USING C14 UREA BREATH TEST | Suvd Tumurbaatar (Mongolia) |
14:08-14:16 | Correlation of Clinical and Endoscopic Findings in Patients with Helicobacter Pylori Infection using Rapid Urease Test: A 10-year Retrospective Study | Virgilio Jr. Sandico Lo (Philippines) |
14:16-14:24 | Can DPO-PCR based tailored-therapy increase the eradication rate of Helicobacter pylori? | Youngwoo Kim (Korea) |
14:24-14:32 | Changes in eradication efficacy of fluoroquinolone-containing triple therapy to Helicobacter pylori in Korea | Nayoung Kim (Korea) |
Nov. 28(Thu) |
White Heron (Main 2F) | |
Chair(s) | Ok-Jae Lee (Korea) | |
14:32-14:40 | Combination therapy with PI3K/mTOR dual inhibitor and chloroquine enhances synergistic apoptotic cell death in EBV-infected gastric cancer cells | Miyoung Kim (Korea) |
14:40-14:48 | MMP-7 expression predicts a poor prognosis in patients with gastric cancer | Taweesak Tongtawee (Thailand) |
14:48-14:56 | Deep learning with long short-term memory to predict gastric neoplasm in asymptomatic population after a health check-up | Hong Jin Yoon (Korea) |
14:56-15:04 | Comparison of intestinal vs diffuse type gastric cancer from the perspective of large-scale signaling network | Jun Hyuk Kang (Korea) |
Nov. 28(Thu) 16:00-17:30 |
Recent updates in management of liver diseases | Convention Hall A+B (4F) |
Chair(s) | Kwang-Hyub Han (Korea), Han Chu Lee (Korea) | |
16:00-16:20 | Clinical development of new HBV therapies | Sang Hoon Ahn (Korea) |
16:20-16:40 | Management of diabetes and dyslipidemia in patients with nonalcoholic steatohepatitis | Seung-Hyun Ko (Korea) |
16:40-17:00 | Autoimmune hepatitis in real practice | Kang Mo Kim (Korea) |
17:00-17:20 | Local ablation therapy of hepatocellular carcinoma | Seung Kak Shin (Korea) |
17:20-17:30 | Discussion |
Nov. 28(Thu) 16:00-17:30 |
New hope for treating pancreatic cancer | Convention Hall C (4F) |
Chair(s) | Volker Ellenrieder (Germany), Ho Soon Choi (Korea) | |
16:00-16:25 | Direct targeting oncogenic Ras mutants by IgG-format cytosol-penetrating antibody | Yong-Sung Kim (Korea) |
16:25-16:45 | Extracelluar vesicles (EVs): exosomes and microvesicles | Yong Song Gho (Korea) |
16:45-17:05 | Targeting altered metabolism in pancreatic cancer | Soo-Youl Kim (Korea) |
17:05-17:25 | Establishment of PDAC organoids model using EUS-guided tissue biopsy: a new window into understanding PDAC and drug discovery | Joo Kyung Park (Korea) |
Nov. 28(Thu) 16:00-17:30 |
Recent updates in UGI diseases | Emerald Hall A (3F) |
Chair(s) | Sang Young Seol (Korea), Sang Woo Lee (Korea) | |
16:00-16:22 | Recent update in Helicobacter pylori infection | Hye-Kyung Jung (Korea) |
16:22-16:44 | Recent updates in treatment of drug-induced PUD | Moon Kyung Joo (Korea) |
16:44-17:06 | Recent updates in diagnosis and treatment of gastric SET | Yonghwan Kwon (Korea) |
17:06-17:28 | Recent updates in treatment of non-variceal upper gastrointestinal bleeding: Introduction of new Korean guideline | Byung-Wook Kim (Korea) |
Nov. 28(Thu) 16:00-17:30 |
Colonic pseudo-obstruction: still unknown motor disorder but clinicians should know | Emerald Hall B (3F) |
Chair(s) | Kyu Joo Park (Korea), Seung-Jae Myung (Korea) | |
16:00-16:22 | What is colonic pseudo-obstruction? | Kee Wook Jung (Korea) |
16:22-16:44 | Radiologic diagnosis of colonic pseudo-obstruction | Hye Jin Kim (Korea) |
16:44-17:06 | Medial approach of colonic pseudo-obstruction | Tae Hee Lee (Korea) |
17:06-17:28 | Surgical approach of colonic pseudo-obstruction | Seung-Bum Ryoo (Korea) |
Nov. 28(Thu) |
Grand Ballroom A (Main 2F) | |
Chair(s) | Ki Baik Hahm (Korea), Ki Taek Nam (Korea) | |
16:00-16:10 | Loss of Slc26a9 results in the disorder of gastric stem cell differentiation and acid/base homeostasis, which is a key event to the development of chronic atrophic gastritis | Xue-Mei Liu (China) |
16:10-16:20 | A Novel LincRNA HERES Epigenetically Regulates CACNA2D3 in Esophageal Squamous Cell Carcinoma | Sang Kil Lee (Korea) |
16:20-16:30 | Tumor suppressor role of miR-363 in esophageal squamous cell carcinoma | Mingxin Zhang (China) |
16:30-16:40 | LPA1-mediated lysophosphatidic acid signaling promotes esophageal cancer by activating PI3K/AKT signaling pathway | Si Liu (China) |
Nov. 28(Thu) |
Grand Ballroom A (Main 2F) | |
Chair(s) | Jeong Seop Moon (Korea), Hwoon-Yong Jung (Korea) | |
16:40-16:50 | Vitamin C solution spray can replace sodium thiosulfate solution spray to completely neutralize iodine staining and substantially relieve the mucosal irritation caused by Lugol chromoendoscopy: a multicenter, randomized, double-blind, parallel trial | Duochen Jin (China) |
16:50-17:00 | IARC's gastric cancer research programs | Jin Young Park (France) |
17:00-17:10 | Development of a Deep Learning based endoscopic image analyses to differentiated malignant gastric ulcers from benign lesions | Youn I Choi (Korea) |
17:10-17:20 | Feasibility of Endoscopic Resection in Gastric Gastrointestinal Stromal Tumor | Yu Ri Kim (Korea) |
17:20-17:30 | H.PYLORI INFECTION RATE AND GASTRIC MUCOSAL CHANGES DURING ENDOSCOPY | Alimaa Sukhbaatar (Mongolia) |
Nov. 29(Fri) 07:30-08:30 |
Meet the Professor | Skylark (Main 2F) |
Chair(s) | Yoon Tae Jeen (Korea) | |
07:30-08:30 | Biologic therapies in IBD: past, present and future | Chang Hwan Choi (Korea) |
Nov. 29(Fri) 07:30-08:30 |
Meet the Professor | White Heron (Main 2F) |
Chair(s) | Moo-In Park (Korea) | |
07:30-08:30 | Pancreatic cancer, GWAS, population stratification, genomics methods for post-GWAS analyses | Laufey Amundadottir (USA) |
Nov. 29(Fri) 09:00-10:30 |
Limits and prospects of acid inhibitors | Convention Hall A (4F) |
Chair(s) | Yong Chan Lee (Korea), Shin Maeda (Japan) | |
09:00-09:22 | Current long-term use of PPI in Asia | Kee Don Choi (Korea) |
09:22-09:44 | PPI and GI tumor: Really associated? | Wai Keung Leung (Hong Kong) |
09:44-10:06 | Is P-CAB really superior to PPI in H. pylori eradication? | Shin Maeda (Japan) |
10:06-10:28 | GERD treatment: which is your choice between PPIs and P-CABs? | Beom Jin Kim (Korea) |
Nov. 29(Fri) 09:00-10:30 |
Optimal strategies of colonoscopy in LGI disease | Convention Hall B (4F) |
Chair(s) | Suk-Kyun Yang (Korea), Sung-Ae Jung (Korea) | |
09:00-09:22 | Endoscopic findings mimicking inflammatory bowel disease | Jaeyoung Chun (Korea) |
09:22-09:44 | How to conduct surveillance of dysplasia in IBD | Soo-Kyung Park (Korea) |
09:44-10:06 | Measures for the high quality colonoscopy | Hoon Sup Koo (Korea) |
10:06-10:28 | Polypectomy strategies base on polyp size and characteristics | Yunho Jung (Korea) |
Nov. 29(Fri) 09:00-10:30 |
Therapeutic advances in constipation | Convention Hall C (4F) |
Chair(s) | Joon Seong Lee (Korea), Noriaki Manabe (Japan) | |
09:00-09:30 | Constipation in older adults | Ching-Liang Lu (Taiwan) |
09:30-10:00 | Opioid -induced constipation | Chong-Il Sohn (Korea) |
10:00-10:30 | New therapeutic strategies for chronic constipation considering colonic transit time | Noriaki Manabe (Japan) |
Nov. 29(Fri) 09:00-10:30 |
Debate in the management of GB cancer | Emerald Hall A (3F) |
Chair(s) | Jaeseon Kim (Korea), Hee Chul Yu (Korea) | |
09:00-09:18 | Appropriate extent of surgery for gallbladder cancer | Seungeun Lee (Korea) |
09:18-09:36 | Feasibility of minimally invasive surgery as radical cholecystectomy: is it time to move on? | Chi-Young Jeong (Korea) |
09:36-09:54 | All about the adjuvant treatment after surgical resection | Jeong Youp Park (Korea) |
09:54-10:12 | How effective is chemotherapy and can it lead to conversion surgery? | Sang Hyub Lee (Korea) |
10:12-10:30 | Case discusssion | Dong Wook Lee (Korea) |
Nov. 29(Fri) 09:00-10:30 |
Plenary Session | Emerald Hall B (3F) |
Chair(s) | Jin-Wook Kim (Korea), Ho Gak Kim (Korea), Yong-Tae Kim (Korea) | |
09:00-09:15 | Integrative multi-omics analysis reveals consensus molecular subtypes reflecting distinct clinical phenotypes of hepatocellular carcinoma. | Sung Hwan Lee (United States) |
09:15-09:30 | Predictors and outcome of emergent liver transplantation for patients with acute-on-chronic liver failure | Ji Eun Kim (Korea) |
09:30-09:45 | The Relationship Between Triceps Skinfold Thickness And Overall Survival of Pancreas, Bile Duct and Gallbladder Cancer | Jong-In Chang (Korea) |
09:45-10:00 | Effect of Bile Acid Composition on Biliary System Infection in Microbial Area | Kihyun Ryu (Korea) |
10:00-10:15 | Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: a multicenter nationwide study | Woo Hyun Paik (Korea) |
10:15-10:30 | Development and Validation of a Novel Prognostic Model for Predicting Lymph Node Metastasis in Early Colorectal Cancer | Ji Hyun Ahn (Korea) |
Nov. 29(Fri) 09:00-10:30 |
Prevention and treatment of cancer-related infection: tip for clinical practice | Diamond Hall (3F) |
Chair(s) | Hyunyong Jeong (Korea), Ji Kon Ryu (Korea) | |
09:00-09:18 | Vaccination for cancer patients; When and What? | Kang Il Jun (Korea) |
09:18-09:36 | Role of myeloid growth factor during chemotherapy | Su Jin Kim (Korea) |
09:36-09:54 | Evaluation and management of cancer-related fever | Hee Seung Lee (Korea) |
09:54-10:12 | Prevention of reactivation of tuberculosis | Chul Ho Oak (Korea) |
10:12-10:30 | Screening and prevention of hepatitis B, C during chemotherapy | Sae Hwan Lee (Korea) |
Nov. 29(Fri) |
Special Lecture | |
Chair(s) | Dong Ki Lee (Korea) | |
11:30-12:00 | BIOCON as a translational platform for the collaboration between researchers and clinicians | Sunghoon Kim (Korea) |
Nov. 29(Fri) |
Presidential Lecture | |
Chair(s) | Jin Hong Kim (Korea) | |
11:00-11:30 | Challenging for Unmet Needs in Pancreatobiliary Diseases | Dong Ki Lee (Korea) |
Nov. 29(Fri) 11:00-12:30 |
Recent updates of esophageal motility disorder | Convention Hall C (4F) |
Chair(s) | Kwang Jae Lee (Korea), Moo-In Park (Korea) | |
11:00-11:22 | Classification | Kee Wook Jung (Korea) |
11:22-11:44 | Diagnostic approach | Yu Kyung Cho (Korea) |
11:44-12:06 | Phamacologic therapheutic apporach | Yang Won Min (Korea) |
12:06-12:28 | Interventional therapheutic approach | Su Jin Hong (Korea) |
Nov. 29(Fri) 11:00-12:30 |
Best treatment opinion for advanced hilar malignancy | Emerald Hall A (3F) |
Chair(s) | Dong Wook Choi (Korea), Sang-Soo Lee (Korea) | |
11:00-11:18 | Preoperative drainage: Surgeon's opinion | Gi Hong Choi (Korea) |
11:18-11:36 | Preoperative drainage: Physician's opinion | Seong-Hun Kim (Korea) |
11:36-11:54 | Best treatment opinion for advanced hilar malignancy: palliative option? | Chang-Min Cho (Korea) |
11:54-12:12 | Advanced hilar malignancy, advanced surgical trial? | Deok Bok Moon (Korea) |
12:12-12:30 | Case discusssion | Sang Hyun Shin (Korea) |
Nov. 29(Fri) 11:00-12:30 |
H.pylori eradication: Current practices | Emerald Hall B (3F) |
Chair(s) | Dongho Lee (Korea), Jun Haeng Lee (Korea) | |
11:00-11:10 | Correlation between the result of antimicrobial susceptibility testing and outcome of eradication therapy for Helicobacter pylori | Young Min Kim (Korea) |
11:10-11:20 | Current trend in the Helicobacter pylori eradication rates of first-line sequential and concomitant therapies in Korea: A nationwide multicenter retrospective study over the 10 years | Bong Eun Lee (Korea) |
11:20-11:30 | Superior efficacy of gastric juice-guided first-line H pylori eradication, a prospective randomized controlled trial | Meng-Shu Hsieh (Taiwan) |
11:30-11:40 | Annual Eradication Rate of Bismuth-Containing Quadruple Therapy as Second-Line Treatment for Helicobacter pylori Infection : a Prospective study for 15 years in the tertiary hospital in Korea | Kichul Yoon (Korea) |
11:40-11:50 | Efficacy and Cost-effectiveness of Helicobacter pylori Eradication: Comparison of Tailored Therapy based on Clarithromycin Resistance and Concomitant Therapy | Kyungeun Lim (Korea) |
11:50-12:00 | Proton Pump Inhibitor Switching Strategy after the failure of Standard Triple Therapy for Helicobacter pylori Eradication. | Jaeyoung Kim (Korea) |
12:00-12:10 | Comparison between conventional quadruple therapy administered four times-a-day and a revised regimen administered twice-a-day for second-line Helicobacter pylori eradication | Ji Yeon Kim (Korea) |
12:10-12:25 | Wrap up lecture | In Kyung Sung (Korea) |
Nov. 29(Fri) 11:00-12:30 |
Recent advances in colorectal cancer screening | Diamond Hall (3F) |
Chair(s) | Dong Kyung Chang (Korea), Joseph J. Y. Sung (Hong Kong) | |
11:00-11:22 | Long-term outcome of FIT-based colorectal cancer screening program | Han-Mo Chiu (Taiwan) |
11:22-11:44 | Recent advances in colorectal cancer screening | Jae Myung Cha (Korea) |
11:44-12:06 | Increasing trend in young- onset colorectal cancer in Asia | Joseph J. Y. Sung (Hong Kong) |
12:06-12:28 | Surveillance recommendations for hereditary colorectal cancer syndrome | Bo-In Lee (Korea) |
Nov. 29(Fri) |
Free Paper (LV1) | Grand Ballroom A (Main 2F) |
Chair(s) | Byungseok Lee (Korea), Youn-Jae Lee (Korea) | |
11:00-11:10 | Increased annual incidence of pyogenic liver abscess and its risk factors: an analysis from HIRA-NPS of South Korea, 20122016 | Jeong-Ju Yoo (Korea) |
11:10-11:20 | Prevalence of metabolic complications associated with severe obesity among Korean children and adolescents : A nationwide study (2011 - 2018) | Tae Hyeong Kim (Korea) |
11:20-11:30 | Outcomes After Non-hepatic Surgeries in Patients with Alcoholic Liver Diseases: A Nationwide Study | Yi-Chun Chou (Taiwan) |
11:30-11:40 | Correlation of infiltration by T cells and macrophages with the severity of liver damage in drug-induced liver injury: implications in responsiveness to steroid therapy | Hyun Yang (Korea) |
11:40-11:50 | Cardiopulmonary and neurologic safety in patients with liver cirrhosis of etomidate-based sedation compared with propofol during upper endoscopy: A double-blind, randomized controlled trial | Jang Han Jung (Korea) |
Nov. 29(Fri) |
Free Paper (LV1) | Grand Ballroom A (Main 2F) |
Chair(s) | Hee Bok Chae (Korea), Byung-Cheol Song (Korea) | |
11:50-12:00 | Three Year Efficacy and Safety of Tenofovir Alafenamide(TAF) Compared to Tenofovir Disoproxil Fumarate(TDF) in Chronic Hepatitis B(CHB) patients | Hyung Joon Kim (Korea) |
12:00-12:10 | Continuing Besifovir Dipivoxil Maleate Versus Switching from Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B : 192 Weeks Results of Phase 3 Trial | Do Seon Song (Korea) |
12:10-12:20 | Detection of HBV integration in the human genome using high-throughput targeted sequencing: oncogenic role of HBV integration | Jeong Won Jang (Korea) |
12:20-12:30 | A Survey on Knowledge and Testing Rate of Hepatitis C in the General Population of South Korea | Gwang Hyeon Choi (Korea) |
Nov. 29(Fri) |
Presidential Lecture | |
Chair(s) | Si Young Song (Korea) | |
11:00-11:40 | Adjuvant therapy after resection of pancreatic cancer | Ji Kon Ryu (Korea) |
Nov. 29(Fri) |
E-poster Oral (PB3) | Flamingo (Main 2F) |
Chair(s) | Jong Kyun Lee (Korea), Kwangbum Cho (Korea) | |
11:00-11:08 | The effect of adjuvant treatment on surgically resected pancreatic adenocarcinoma according to 8th edition AJCC TNM stage system: a retrospective single center experience | Chang Min Cho (Korea) |
11:08-11:16 | Lymph Node Ratio as Valuable Predictor in Pancreatic Cancer Treated with R0 Resection and Adjuvant Treatment | Sang Hyub Lee (Korea) |
11:16-11:24 | ASSOCIATION OF DIABETES MELLITUS FOR LONG TERM FOLLOWED BRANCH DUCT IPMN ALONG INTERNATIONAL GUIDELEIN IPMN 2017 | Daisuke Masuda (Japan) |
11:24-11:32 | The association between use of statin or aspirin and pancreatic ductal adenocarcinoma : A nested case-control study in the Korean nationwide cohort | Jin Ho Choi (Korea) |
Nov. 29(Fri) |
E-poster Oral (PB3) | Flamingo (Main 2F) |
Chair(s) | Kwang Hyuck Lee (Korea), Min Kyu Jung (Korea) | |
11:32-11:40 | Comparison of first-line chemotherapy for pancreatic cancer : aspect of prognosis according to chemo-response of Ca19-9. | Sung Yong Han (Korea) |
11:40-11:48 | Comparison of Efficacy Between FOLFIRINOX and Gemcitabin plus nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer | Min Su You (Korea) |
11:48-11:56 | Comparison of outcomes between FOLFIRINOX and Gemcitabine plus tarceva for pancreatic cancer | Sung Bum Kim (Korea) |
11:56-12:04 | Serial CTC monitoring and its molecular genetic analysis during treatment in patients with Pancreatic Cancer | Chan Mi Heo (Korea) |
12:04-12:12 | Impacts of new-onset and longstanding diabetes on the incidence and mortality of pancreatic cancer: population based big-cohort study | Seon Mee Park (Korea) |
Nov. 29(Fri) |
E-poster Oral (LGI3) | Skylark (Main 2F) |
Chair(s) | Yun Jeong Lim (Korea), Jonghoon Lee (Korea) | |
11:00-11:08 | Comparison of treatment and 1-year outcomes between pediatric Crohn's disease and ulcerative colitis in Korea: results from a multicenter, registry-based, retrospective cohort study | Yeoun Joo Lee (Korea) |
11:08-11:16 | Detection of tumor necrosis factor-a in colon tissue of ulcerative colitis patients using Two-Photon Microscopy | Seong Ji Choi (Korea) |
11:16-11:24 | Prognostic factors in Intestinal Behcet's disease | Yu Young Joo (Korea) |
11:24-11:32 | A Newly Developed Metric, PSDrest Predicts the Presence of Defecatory Disorders and Highly Correlates with the Balloon Expulsion Test | Tengku Ahmad Iskandar Tengku Alang (Malaysia) |
Nov. 29(Fri) |
E-poster Oral (LGI3) | Skylark (Main 2F) |
Chair(s) | You Sun Kim (Korea), Bong Min Ko (Korea) | |
11:32-11:40 | Efficacy and Safety of D-sorbitol and Picosulfate plus Ascorbic acid, a new bowel cleansing solution for colonoscopy: Prospective Multicenter Randomized Study | Seung Yong Shin (Korea) |
11:40-11:48 | Atopic Diseases are Associated with the Development of Inflammatory Bowel Diseases: A Nationwide Population-based Study | Hosim Soh (Korea) |
11:48-11:56 | Comparison between pediatric Crohn's disease and ulcerative colitis at diagnosis in Korea: results from a multicenter, registry-based, retrospective cohort study | Seung Kim (Korea) |
11:56-12:04 | Trends and Risk factors of Middle and Old-aged Crohn's Disease; A nationwide study in South Korea | Jung Min Moon (Korea) |
Nov. 29(Fri) 11:00-12:30 |
E-poster Oral (Motility1) | White Heron (Main 2F) |
Chair(s) | Hyun Jin Kim (Korea), Young Hoon Youn (Korea) | |
11:00-11:08 | Pelvic Floor Dysfunction in Chronic Constipated Children in Korea | Sun Hwan Bae (Korea) |
11:08-11:16 | The change of intestinal barrier as aging and irrtable bowel syndrome | Yonghwan Kwon (Korea) |
11:16-11:24 | NON-OBESE NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH EROSIVE ESOPHAGITIS | Ki Bae Bang (Korea) |
11:24-11:32 | Antidepressant for Symptoms Remission of Gastroesophageal Reflux: A Network Meta-Analysis | Xiao-Bei Si (China) |
11:32-11:40 | Clinical Features of Severely Constipated Children: Comparison between Infrequent Bowel Movement and Fecal Soiling Groups | Sun Hwan Bae (Korea) |
11:40-11:48 | Association between diarrhoea and clinical outcomes in critically ill patients receiving enteral nutrition. | Mazuin Kamarul Zaman (Malaysia) |
11:48-11:56 | Altered Intestinal Permeability and Effect of Mosapride and Glutamine on Postoperative Ileus in a Guinea Pig Model | Young Min Kim (Korea) |
Nov. 29(Fri) 12:30-13:30 |
Luncheon Symposium 02 (OLYMPUS) | Convention Hall A (4F) |
Chair(s) | Yong Chan Lee (Korea) | |
12:30-13:30 | The "Cold" is blowing. How far and how strong? - Efficacy & safety of cold snare resection for colon poly. |
Hyun Gun Kim (Korea) |
Nov. 29(Fri) 12:30-13:30 |
Luncheon Symposium 03 (CJ HealthCare) | Convention Hall B (4F) |
Chair(s) | Jae Jun Kim (Korea) | |
12:30-13:30 | Tegoprazan, a promissing new option in the medical management of GERD | Nayoung Kim (Korea) |
Nov. 29(Fri) 14:00-15:30 |
Intestinal Failure: Nutritional Therapy in Medical Practice | Convention Hall A (4F) |
Chair(s) | Jong-Jae Park (Korea), Yong Joo Kim (Korea) | |
14:00-14:30 | Nutritional approach to pediatric intestinal failure | Seak Hee Oh (Korea) |
14:30-15:00 | Intestinal adaptation and management of short bowel syndrome | Hyuk-Joon Lee (Korea) |
15:00-15:30 | Tips for successful home parenteral nutrition | Jin Soo Moon (Korea) |
Nov. 29(Fri) 14:00-15:30 |
Approach to cystic hepatic lesions: from simple cyst, complicated cyst, polycystic liver disease, biliary cystadenoma, and cystadenocarcinoma | Convention Hall B (4F) |
Chair(s) | Won Young Tak (Korea), Hee-Jung Wang (Korea) | |
14:00-14:22 | Differential diagnosis of cystic lesions | Jin-Young Choi (Korea) |
14:22-14:44 | Follow-up strategy | Yanghyun Baek (Korea) |
14:44-15:06 | Medical and interventional management | Pyo Nyun Kim (Korea) |
15:06-15:28 | Surgical management | Nam-Joon Yi (Korea) |
Nov. 29(Fri) 14:00-15:30 |
Gut microbiota and diet in IBS | Convention Hall C (4F) |
Chair(s) | Myung-Gyu Choi (Korea), Kyu Chan Huh (Korea) | |
14:00-14:22 | Gut microbiota in the pathophysiology of IBS | Chang Hwan Choi (Korea) |
14:22-14:44 | Interactions between diet and gut microbiota | Kyung Ho Song (Korea) |
14:44-15:06 | Diet therapies for IBS | Seong-Eun Kim (Korea) |
15:06-15:28 | Microbiota-based therapies for IBS | Young-Seok Cho (Korea) |
Nov. 29(Fri) 14:00-15:30 |
Improve your ERCP skill for CBD stone removal | Emerald Hall A (3F) |
Chair(s) | Seokho Dong (Korea), Sang-Woo Cha (Korea) | |
14:00-14:22 | Optimal cannulation | Kwang Ro Joo (Korea) |
14:22-14:44 | Choice of appropriate accessories | Min Jae Yang (Korea) |
14:44-15:06 | Endoscopic sphincterotomy and endoscopic papillary balloon dilation | Jin-Seok Park (Korea) |
15:06-15:28 | Prevention of complication | Tae Yoon Lee (Korea) |
Nov. 29(Fri) 14:00-15:30 |
Colorectal cancer: New topic and issue | Emerald Hall B (3F) |
Chair(s) | Seunja Park (Korea), Yoon Tae Jeen (Korea) | |
14:00-14:22 | The current understanding and optimal approach of early-onset colorectal cancer | Jong Pil Im (Korea) |
14:22-14:44 | Carbon-ion therapy for recurrent rectal cancer | Jee Suk Chang (Korea) |
14:44-15:06 | Emerging treatment in recurrent and metastatic colorectal cancer | Seong Hoon Shin (Korea) |
15:06-15:28 | Future clinical and translational research in colorectal cancer | Bun Kim (Korea) |
Nov. 29(Fri) 14:00-15:30 |
Battle against cholangiocarcinoma: bench to clinical application | Diamond Hall (3F) |
Chair(s) | Hong-Sik Lee (Korea), Chang-Nyol Paik (Korea) | |
14:00-14:22 | Genetic and transcriptomic analyses of the biliary tract cancer | Tatsuhiro Shibata (Japan) |
14:22-14:44 | Development of patient-derived preclinical models for cholangiocarcinoma | Yun-Hee Kim (Korea) |
14:44-15:06 | Circulating biomarkers in cholangiocarcinoma | Nai-Jung Chiang (Taiwan) |
15:06-15:28 | Developmental therapeutics | Seungmin Bang (Korea) |
Nov. 29(Fri) |
Free Paper (LGI1) | Grand Ballroom A (Main 2F) |
Chair(s) | Sang Wook Kim (Korea), Byong Duk Ye (Korea) | |
14:00-14:10 | Development of Real-time Deep Learning Based Colorectal Polyp Detection System using Unedited Videos of Standard Colonoscopies | Youn I Choi (Korea) |
14:10-14:20 | Preventive effects on colorectal cancer by colonoscopy differ depending on gender and metabolic syndrome in 40s. | Su Young Kim (Korea) |
14:20-14:30 | Effect of Diminutive polyps with HGD on surveillance colonoscopy. | JAEHO PARK (Korea) |
14:30-14:40 | Factors affecting the characteristics of advanced colorectal adenoma in diabetic patients | Sang Hoon Lee (Korea) |
Nov. 29(Fri) |
Free Paper (LGI1) | Grand Ballroom A (Main 2F) |
Chair(s) | Tae Oh Kim (Korea), Chang Soo Eun (Korea) | |
14:40-14:50 | Risk of colorectal neoplasm development in kidney transplant recipients | Younghee Choe (Korea) |
14:50-15:00 | Therapeutic colonoscopy does not reduce the incidence of colorectal cancer in the elderly over 80 years: A nationwide population-based cohort study. | Su Young Kim (Korea) |
15:00-15:10 | Discovery of Hesperidin based novel AMPK/mTOR kinase inhibitor against colorectal cancer cells | Vikas Kumar (India) |
Nov. 29(Fri) |
E-poster Oral (PB4) | Flamingo (Main 2F) |
Chair(s) | Seung-Ok Lee (Korea), Jae Hyuck Chang (Korea) | |
14:00-14:08 | Current status of basic technique of endoscopic retrograde cholangiopancreatography in Korea: results from a national survey | Jae Min Lee (Korea) |
14:08-14:16 | Physician-Controlled Wire-Guided Cannulation with Short Guidewire System for Endoscopic Retrograde Cholangiopancreatography Compared to Assistant-Controlled Wire-Guided Cannulation with Long Guidewire System; Single Center Experience with Large Cohort | Minje Sung (Korea) |
14:16-14:24 | Can prophylactic argon plasma coagulation reduce delayed post-papillectomy bleeding? A prospective randomized multicenter trial | Jae Kook Yang (Korea) |
14:24-14:32 | Usefulness of unflared intraductal short fully covered self-expandable metallic stent for endoscopic removal of bile duct stones complicated by biliary stricture | Jae Keun Park (Korea) |
14:32-14:40 | A short length stent with an anti-migration design is useful for the treatment of high-level biliary anastomotic stricture after a biliary operation | Sung Ill Jang (Korea) |
Nov. 29(Fri) |
E-poster Oral (PB4) | Flamingo (Main 2F) |
Chair(s) | Tae Hyeon Kim (Korea), Chang-il Kwon (Korea) | |
14:40-14:48 | Efficacy of Early ERCP in Primary and Secondary Distal Malignant Biliary Obstruction | Min Su You (Korea) |
14:48-14:56 | Usefulness and safety of EUS-FNB using a franseen needle for pancreatic lesions. | takashi kurosawa (Japan) |
14:56-15:04 | EUS-guided biliary drainage for right intrahepatic bile duct obstruction | Masanori Yamada (Japan) |
15:04-15:12 | Pre-clinical animal test using novel hydrophilic plastic stent system in swine models of biliary stricture | Jae Keun Park (Korea) |
15:12-15:20 | Impact of Balloon Inflation on the Insertion of Endoscopic Ultrasound: A prospective, randomized controlled trial | Jinwoo Kang (Korea) |
Nov. 29(Fri) |
E-poster Oral (UGI3) | White Heron (Main 2F) |
Chair(s) | Joo Young Cho (Korea), Moo-In Park (Korea) | |
14:00-14:08 | Using Deep Learning System in Endoscopy for Screening of Early Esophageal Squamous Cell Carcinoma | Yun-Shi Zhong (China) |
14:08-14:16 | Real-time Automated Diagnosis of Precancerous Lesion and Early Esophageal Squamous Cell Carcinoma Using A Deep Learning Model | LinJie Guo (China) |
14:16-14:24 | Auscultation-Assisted Bedside Postpyloric Placement of Feeding Tube in Critically Ill Patients: a Multicenter, Prospective, Observational Study | Jianguo Xiao (China) |
14:24-14:32 | The use of proton-pump inhibitors has a significant risk of fatty liver disease: a nationwide cohort study | Tae Jun Kim (Korea) |
14:32-14:40 | Randomised clinical trial: A double-blind, randomised, active-controlled, phase 3 study to evaluate the safety and efficacy of Tegoprazan in patients with gastric ulcer | Yu Kyung Cho (Korea) |
Nov. 29(Fri) |
E-poster Oral (UGI3) | White Heron (Main 2F) |
Chair(s) | Nayoung Kim (Korea), Jin Tae Jung (Korea) | |
14:40-14:48 | Is Gastric Gastrointestinal Stromal Tumor (GIST) with Acute Bleeding Worrisome Feature? | Seongyul Ryu (Korea) |
14:48-14:56 | Upper gastrointestinal neoplasm in Familial Adenomatous Polyposis: a single-center, retrospective study | Jin Hee Noh (Korea) |
14:56-15:04 | A comparison of the Tammaro Score and the Glasgow-Blatchford score in predicting outcomes and the need for intervention among patients with non-variceal UGIB | Jamie Lynn Co (Philippines) |
15:04-15:12 | Endoscopic Subserosal Dissection for Gastric tumors: 18- case series in a Single Center | Jihyun Han (Korea) |
15:12-15:20 | Gastrointestinal foreign body in Korean children: a nationwide study | Tae Hyeong Kim (Korea) |
Nov. 29(Fri) 16:00-17:30 |
Recent debates on EGC with undifferentiated type histology | Convention Hall A (4F) |
Chair(s) | Jae Moon Bae (Korea), Jae J Kim (Korea) | |
16:00-16:22 | Biologic and clinical features of EGC with undifferentiated type histology | Hye Seung Lee (Korea) |
16:22-16:44 | Optimal management for EGC with undifferentiated type histology: Gastroenterologist's view | Jun Chul Park (Korea) |
16:44-17:06 | Optimal management for EGC with undifferentiated type histology: Surgeon's view | Ho Seok Seo (Korea) |
17:06-17:17 | Recent debates on EGC with undifferentiated-type histology: Case-based discussion | Jong-Han Kim (Korea) |
17:17-17:28 | Case-based discussion | Hyo-Joon Yang (Korea) |
Nov. 29(Fri) 16:00-17:30 |
Successful Transition From Pediatric To Adult Care: What We Have To Know | Convention Hall B (4F) |
Chair(s) | Young Sook Park (Korea), Byung-Ho Choe (Korea) | |
16:00-16:22 | Childhood-onset IBD vs. adult-onset IBD | Jung Ok Shim (Korea) |
16:22-16:44 | Nutritional therapies in IBD – from children to adults | Sang Yong Kim (Korea) |
16:44-17:06 | Understanding adolescent IBD patients | Yeoun Joo Lee (Korea) |
17:06-17:28 | The meaning of graduation from pediatric IBD care | Sung-Ae Jung (Korea) |
Nov. 29(Fri) 16:00-17:30 |
Effective multidisciplinary approaches to IHD stone | Convention Hall C (4F) |
Chair(s) | Jin Hong Kim (Korea), Kyo-Sang Yoo (Korea) | |
16:00-16:22 | Endoscopic intervention (KPBA) | Mitsuhiro Kida (Japan) |
16:22-16:44 | Radiologic intervension (Radiology) | Myungsu Lee (Korea) |
16:44-17:06 | Surgical approach (KAHPBS) | Seogki Min (Korea) |
17:06-17:28 | Case discusssion | Seung Bae Yoon (Korea) |
Nov. 29(Fri) 16:00-17:30 |
Updated KASL guidelines: HBV, Cirrhosis | Emerald Hall A (3F) |
Chair(s) | Soon Koo Baik (Korea), Jin-Woo Lee (Korea) | |
16:00-16:22 | HBV: Patients with elevated serum HBV DNA levels, but normal ALT levels | Jeong-Hoon Lee (Korea) |
16:22-16:44 | HBV: Pregnant women and women preparing for pregnancy | Jung Hyun Kwon (Korea) |
16:44-17:06 | Management of varices | Yeon Seok Seo (Korea) |
17:06-17:28 | The management of hepatic encephalopathy | Sang Gyun Kim (Korea) |
Nov. 29(Fri) 16:00-17:30 |
Topic Forum (PB1) | Emerald Hall B (3F) |
Chair(s) | Seon Mee Park (Korea), Seungmin Bang (Korea) | |
16:00-16:10 | Establishment of Patient Derived Pancreatic Ductal Adenocarcinoma Organoids platform and analysis of its Characteristics | Joo Hye Song (Korea) |
16:10-16:20 | Establishment of patient-derived pancreatic cancer organoid by means of EUS-FNA: Comparison between core biopsy tissues and organoids | Jee Hyung Lee (Korea) |
16:20-16:30 | Successful establishment of pancreatic cancer patient-derived orthotopic xenograft models | Jun Hyuk Kang (Korea) |
16:30-16:40 | Whole Exome Sequencing of Primary Pancreatic Ductal Adenocarcinoma and Paired Liver Metastasis | Tae-Se Kim (Korea) |
16:40-16:50 | Integrative analysis for genomic profiling of multifocal intrahepatic cholangiocarcinoma: Clinically relevant evidence for precision therapeutic strategies | Sung Hwan Lee (United States) |
16:50-17:00 | Single Cell Analysis of Primary and Metastatic Pancreatic Cancer Cells | Nam Joong Kim (Korea) |
17:00-17:10 | Analysis of Extracellular Vesicles (EVs) and Clinical Application in Pancreatic Cancer | Myung Ji Goh (Korea) |
17:10-17:25 | Topic forum | Joo Kyung Park (Korea) |
Nov. 29(Fri) 16:00-17:30 |
Toward the Precision Medicine | Diamond Hall (3F) |
Chair(s) | Laufey Amundadottir (USA), Tae Il Kim (Korea), Sun Young Rha (Korea) | |
16:00-16:20 | Expression quantitative trait locus (eQTL) and chromatin interaction approaches to understand biology of pancreatic cancer risk loci from GWAS | Laufey Amundadottir (USA) |
16:20-16:40 | Exploration of aminoacyl-tRNA synthetases for future medicine | Sunghoon Kim (Korea) |
16:40-17:00 | TGFß signalling and NFAT transcription factors in cancer development and progression | Volker Ellenrieder (Germany) |
17:00-17:20 | Intrinsic Cancer Vaccination | In San Kim (Korea) |
17:20-17:30 | Q&A |
Nov. 29(Fri) |
Free Paper (LV2) | Grand Ballroom A (Main 2F) |
Chair(s) | Kyun-Hwan Kim (Korea), Sung Kyu Choi (Korea) | |
16:00-16:10 | microRNA99a restricts hepatitis C virus replication by blocking mTORC1-mediated de novo lipogenesis | Pil Soo Sung (Korea) |
16:10-16:20 | Integrated omics analysis identifies novel targets for aspirin mediated regression of liver fibrosis | Adil Bhat (India) |
16:20-16:30 | MicroRNA-101-3p Suppresses Hepatic Stellate Cell Activation and Promotes the Hepatic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Targeting EZH2 | Jung Hoon Cha (Korea) |
16:30-16:40 | Realworld efficacy of M2BPGi on diagnosing liver fibrosis in chronic hepatitis patients | Young Youn Cho (Korea) |
16:40-16:50 | Protein intake pattern and effect of protein intake in patient with chronic liver disease | Jin Hwa Park (Korea) |
Nov. 29(Fri) |
Free Paper (LV2) | Grand Ballroom A (Main 2F) |
Chair(s) | Il Han Song (Korea), Woo Jin Chung (Korea) | |
16:50-17:00 | MiR-148a-5p Attenuates the Expression of CD44 and Suppresses Liver Cancer Progression in Hepatocellular Carcinoma | Na Ri Park (Korea) |
17:00-17:10 | Factors associated with rapid progressive disease despite transarterial chemoembolization in intermediate stage hepatocellular carcinoma: Potential implications for treatment selection | Jun Young Kim (Korea) |
17:10-17:20 | Lymphocyte to Monocyte Ratio Based Nomogram for Predicting Outcomes of Hepatocellular Carcinoma Treated with Sorafenib | Yeonjung Ha (Korea) |
17:20-17:30 | Pure laparoscopic versus open right hepatectomy in live liver donors: a propensity score matched analysis | Suk Kyun Hong (Korea) |
Nov. 30(Sat) 07:30-08:30 |
Meet the Professor | Flamingo (Main 2F) |
Chair(s) | Sung Kwan Shin (Korea) | |
07:30-08:30 | Endoscopic management for obesity | Roman Turro Arau (Spain) |
Nov. 30(Sat) 07:30-08:30 |
Meet the professor | Skylark (Main 2F) |
Chair(s) | Jin Lee (Korea), Jin-Hyeok Hwang (Korea) | |
07:30-08:30 | Bile acids and cancer | David Q.H. Wang (USA) |
Nov. 30(Sat) 07:30-08:30 |
Breakfast Symposium (SYSMEX KOREA) | Convention Hall C (4F) |
Chair(s) | Do Young Kim (Korea) | |
07:30-08:30 | Current status and perspective of a new fibrosis marker, M2BPGi in Japan | Keisuke Hino (Japan) |
Nov. 30(Sat) |
Global unsolved issues in Viral hepatitis | Convention Hall C (4F) |
Chair(s) | Kwang-Hyub Han (Korea), Myung-Ken Lee (Korea), Markus Peck (Austria) | |
08:30-09:00 | Current situation and strategic plan of Hepatitis B in Africa | Djoudalbaye Benjamin (Ethiopia) |
09:00-09:20 | Development of international program for Hepatitis B management | Hoon Sang Lee (Korea) |
09:20-09:40 | Economic Burden and Cost effective Control of Viral hepatitis | Yock Young Dan (Singapore) |
09:40-10:00 | Global strategy to prevent viral hepatitis; focusing on introducing Hepatitis B birth dose in low- and middle-income countries | Daniel Rhee (Korea) |
10:00-10:20 | Role of IASL to strengthen global partnership | Kwang-Hyub Han (Korea) |
10:20-10:30 | Discussion |
Nov. 30(Sat) |
Inter-disciplinary approach in IBD | Convention Hall A (4F) |
Chair(s) | Won Ho Kim (Korea), Suk-Hwan Lee (Korea) | |
09:00-09:22 | Perianal Crohn’s disease: Stem cell therapy or anti-TNFs? | Yong Sik Yun (Korea) |
09:22-09:44 | What surgeons need to know: updates of biologics and small molecules | Kang-Moon Lee (Korea) |
Nov. 30(Sat) |
Management of a visible high-grade dysplasia in a patient with ulcerative pancolitis | Convention Hall A (4F) |
Chair(s) | Won Ho Kim (Korea), Suk-Hwan Lee (Korea) | |
09:45-10:07 | Total proctocolectomy should be first | Hee Cheol Kim (Korea) |
10:07-10:29 | Endoscopic resection should be first | Dong-Hoon Yang (Korea) |
Nov. 30(Sat) 09:00-10:30 |
Video Session (KSG-UGI) | Convention Hall B (4F) |
Chair(s) | Ping-Hong Zhou (China), Vu Van Khien (Vietnam), Gwang Ha Kim (Korea) | |
09:00-09:18 | Magnifying endoscopy with NBI in the stomach, especially for EGC | Gwang Ha Kim (Korea) |
09:18-09:36 | Active GI bleeding: How to treat | Hanglak Lee (Korea) |
09:36-09:54 | ESD with traction method | Hyunsoo Chung (Korea) |
09:54-10:12 | POEM, the submucosal endoscopy: Tips and know-how to be an expert | Do Hoon Kim (Korea) |
10:12-10:30 | Endoscopic management of esophageal fistula and anastomotic leak | Hyuk Soon Choi (Korea) |
Nov. 30(Sat) 09:00-10:30 |
Tips to become a good journal | Emerald Hall A (3F) |
Chair(s) | Young S. Kim (USA), Sang Woo Lee (Korea) | |
09:00-09:30 | Publication ethics | Dong Soo Han (Korea) |
09:30-10:00 | Past and new decade of Gut and Liver | Jong Pil Im (Korea) |
10:00-10:30 | Strategy to be an SCI journal: Clinical and Molecular Hepatology | Yoon Jun Kim (Korea) |
Nov. 30(Sat) 09:00-10:30 |
Obsetiy and metabolic syndrome: Where are we now and where are we going ?: pathophysiology, epidemiology, diagnosis, classification etc. | Emerald Hall B (3F) |
Chair(s) | David Q.H. Wang (USA), Hyun Wook Baik (Korea), Joo-Ho Lee (Korea) | |
09:00-09:22 | Pathophsiology of metabolic syndrome: The cutting edge | David Q.H. Wang (USA) |
09:22-09:44 | Gut microbiome and metabolic syndrome | Myung-Shik Lee (Korea) |
09:44-10:06 | Recent Issues in diagnosis and classification | Yang-hyun Kim (Korea) |
10:06-10:28 | Metabolic syndrome in children and adolescents | Ki Soo Kang (Korea) |
Nov. 30(Sat) 09:00-10:30 |
Which treatment in locally advanced cancers | Diamond Hall (3F) |
Chair(s) | Jin Tae Jung (Korea), Young-Woo Kim (Korea) | |
09:00-09:22 | Locally advanced Esophageal Cancer; Pro CCRT versus Pro Surgery | Young Sin Cho (Korea) |
09:22-09:44 | Locally advanced Esophageal Cancer; Pro CCRT versus Pro Surgery | Jin-Jo Kim (Korea) |
09:44-10:06 | Locally advanced Gastric cancer; neadjuvant versus adjuvant therapy | Hee Seok Moon (Korea) |
10:06-10:28 | Locally advanced Gastric cancer; neadjuvant versus adjuvant therapy | Beom Su Kim (Korea) |
Nov. 30(Sat) |
Grand Ballroom A (Main 2F) | |
Chair(s) | In Kyung Sung (Korea), Kee Wook Jung (Korea) | |
09:00-9:10 | Oesophageal motility disorders in systemic sclerosis: Observational study | sara Ghani (Morocco) |
09:10-9:20 | Long-term results of surgical treatment of GERD in combination with a hiatal hernia | Saidrakhim Lukmonov (Uzbekistan) |
09:20-9:30 | Classification of functional dyspepsia using resting-state functional brain network: a machine learning study | Tao Yin (China) |
09:30-9:40 | Predictors of Decreased Stool Frequency in Constipated Elderly: A Hierarchical Linear Regression Model Approach | Khairil Khuzaini Zulkifli (Malaysia) |
Nov. 30(Sat) |
Grand Ballroom A (Main 2F) | |
Chair(s) | Sang Kil Lee (Korea), Jung-Ho Park (Korea) | |
09:40-9:50 | 99mTc-Phytate is a Suitable Cheaper Alternative to the Gold-standard 99mTc-Sulfur Colloid in Gastric Emptying Scintigraphy: A Validation Study Among Healthy Volunteers | Tengku Ahmad Iskandar Tengku Alang (Malaysia) |
09:50-10:00 | The assessment of high-resolution oesophageal manometry with non obstructive dysphagia | sara Ghani (Morocco) |
10:00-10:10 | Result of colonic Lactobacillus of relativity healthy adults and correlate the link between dairy consumption | Amarjargal Batdelger (Mongolia) |
Nov. 30(Sat) |
Nursing session (KASID) | Flamingo (Main 2F) |
Chair(s) | Jin-Oh Kim (Korea), Young-Seok Cho (Korea) | |
09:00-09:22 | Perioperative pharmacological considerations in IBD | Shin Ju Oh (Korea) |
09:22-09:44 | Complementary and alternative medicine for IBD | Eun ae Kang (Korea) |
09:44-10:06 | Opportunistic infections in IBD: Case-based discussion | Sang Hyoung Park (Korea) |
10:06-10:28 | Adult vaccination recommendations focused in IBD | Won-Suk Choi (Korea) |
Nov. 30(Sat) 11:00-12:30 |
Korean GI Frontiers | Convention Hall A (4F) |
Chair(s) | Won Ho Kim (Korea), Jong Sun Rew (Korea) | |
11:00-11:22 | Transarterial chemoembolization plus external beam radiotherapy vs. sorafenib in HCC | Young-Suk Lim (Korea) |
11:22-11:44 | Helicobacter pylori eradication for the prevention of metachronous gastric cancer | Il Ju Choi (Korea) |
11:44-12:06 | Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in Crohn's disease | Youngho Kim (Korea) |
12:06-12:28 | Observation time in esophagogastroduodenoscopy | Jae Myung Park (Korea) |
Nov. 30(Sat) 11:00-12:30 |
Video Session (KSG-LGI) | Convention Hall B (4F) |
Chair(s) | Han-Mo Chiu (Taiwan), Bo-In Lee (Korea) | |
11:00-11:22 | Diagnosis and differential diagnosis of colorectal polyps: Up-to-date imaging technique | Han-Mo Chiu (Taiwan) |
11:22-11:44 | Surveillance for dysplasia in IBD: chromoendoscopy and image-enhanced endoscopy | Sung Noh Hong (Korea) |
11:44-12:06 | Cold method for colon polpectomy; Why, When, and How? | Bong Min Ko (Korea) |
12:06-12:28 | Tips for complete and safe colorectal ESD for difficult cases | Bo-In Lee (Korea) |
Nov. 30(Sat) |
Special lectures / Opening ceremony | Convention Hall C (4F) |
Chair(s) | Kwang-Hyub Han (Korea) | |
11:00-11:15 | Opening ceremony | |
11:15-11:30 | Long journey of IASL | Samuel Lee (Canana) |
Nov. 30(Sat) |
Professional platform: How to Start and Build-up Academic Career - I | Convention Hall C (4F) |
Chair(s) | Samuel Lee (Canana), Jacob George (Australia) | |
11:30-11:50 | How to conduct a good research | Henry LY Chan (Hong Kong) |
11:50-12:10 | How to write a good paper | Samuel Lee (Canana) |
12:10-12:30 | How to handle big data | Young-Suk Lim (Korea) |
Nov. 30(Sat) 11:00-12:30 |
Go to the deep inside of GI disease | Emerald Hall A (3F) |
Chair(s) | Tae Il Kim (Korea), Thomas Roberts (USA) | |
11:00-11:22 | Recent update of physiology research of GI sensation and motility | Jae Hak Kim (Korea) |
11:22-11:44 | The future of PI3K directed therapies in cancer treatment | Thomas Roberts (USA) |
11:44-12:06 | Recent update of brain-gut-microbiome axis | Geom Seog Seo (Korea) |
12:06-12:28 | Recent update of pathophysiology and therapeutic target of IBD | Seongjoon Ko (Korea) |
Nov. 30(Sat) 11:00-12:30 |
Obestiy and metabolic syndrome: What are the links with GI diseases? | Emerald Hall B (3F) |
Chair(s) | Seung-Jae Myung (Korea), Joo Hyun Sohn (Korea) | |
11:00-11:22 | NAFLD | Seung Up Kim (Korea) |
11:22-11:44 | Obesity and functional gastrointestinal disorders | Ju Yup Lee (Korea) |
11:44-12:06 | Obestiy and metabolic syndrome: What are the links with GI diseases? | Byung Chang Kim (Korea) |
12:06-12:28 | Pancreatobiliary diseases | Dong Hee Koh (Korea) |
Nov. 30(Sat) |
Presidential Lecture | Diamond Hall (3F) |
Chair(s) | Seokho Dong (Korea) | |
11:00-11:40 | Biology of cholangiocytes: from bench to bedside | Ho Soon Choi (Korea) |
Nov. 30(Sat) |
Special Lecture | Diamond Hall (3F) |
Chair(s) | Ho Soon Choi (Korea) | |
11:40-12:20 | Targeting genome dynamics in pancreatic cancer | Volker Ellenrieder (Germany) |
Nov. 30(Sat) 11:00-12:30 |
Grand Ballroom A (Main 2F) | |
Chair(s) | Tae Nyeun Kim (Korea), Dong Wan Seo (Korea) | |
11:00-11:10 | Comparison of Liquid-based Cytology with Conventional Smear Cytology for Endoscopic Ultrasound-guided Fine Needle Aspiration of Solid Pancreatic Masses: Prospective Randomized Non-inferiority Study | Jung Won Chun (Korea) |
11:10-11:20 | Direct peroral cholangioscopy using a new multibending ultra-slim endoscope without device or scope assistance: a large single center experience | Yun Nah Lee (Korea) |
11:20-11:30 | Efficacy of endobiliary radiofrequency ablation plus stenting versus stenting alone in patients with inoperable hilar cholangiocarcinoma | Yun Nah Lee (Korea) |
11:30-11:40 | Innovation of EUS-guided Transmural Gallbladder Drainage using a Novel Self-Expending Metal Stent | Gunn Huh (Korea) |
11:40-11:50 | EUS-guided antegrade metal stent deployment for benign hepaticojejunostomy anastomosis stricture | Atsushi Okuda (Japan) |
11:50-12:00 | Pure NOTES retrograde cholecystectomy using a single channel flexible endoscope: a pilot experiment in a porcine model | Saif Ullah (China) |
Topic forum | Jaihwan Kim (Korea) |
Nov. 30(Sat) |
E-poster Oral (KSGC1) | Flamingo (Main 2F) |
Chair(s) | Dong-Uk Kim (Korea), Eun Sun Kim (Korea) | |
11:00-11:08 | Response after preoperative long course chemoradiotherapy in locally advanced rectal cancer | May Thin Hlaing (Myanmar) |
11:08-11:16 | The Feasibility and Clinical Outcomes of Endoscopic Full Thickness Resection Assisted Laparoscopic Surgery for Duodenal Neuroendocrine Neoplasms | Sunah Suk (Korea) |
11:16-11:24 | comparison of short-term and lond-term results in the treatment of patients with malignant colorectal obstruction:emergency resection or stenting or transanal decompression tube. | Aleksandr Vodoleev (Russian Federation) |
11:24-11:32 | Qurecetin loaded Nano-Lipidic Carriers exerts Diethylnitrosamine induced Hepatic Cancer via attenuation ofcellular inflammation and cell proliferation | Vikas Kumar (India) |
11:32-11:40 | An alternative approach to Radiological image guided Endoscopic Ultrasound- Guided Liver Lesion Biopsy (EUS LLB) with atypical malignancies. | Muhammad Manzoor Ul Haq (Pakistan) |
Nov. 30(Sat) |
Flamingo (Main 2F) | |
Chair(s) | Seonghwan Kim (Korea), Jeong Youp Park (Korea) | |
11:40-11:48 | Clinical Profile of Patients with Hepatocellular Carcinoma at St. Lukes Medical Center and Cardinal Santos Medical Center from 2003-2018 | John Alfredo Raphael Perez Pangilinan (Philippines) |
11:48-11:56 | Just the Tip of the Iceberg: A Case Report on Two Patients Presenting with Sister Mary Josephs Nodule | Carlos Paolo Francisco (Philippines) |
11:56-12:04 | Mucinous Colorectal Cancer Presenting as Pseudomyxoma Peritonei: A Case report | Clarissa Cruz (Philippines) |
12:04-12:12 | A 62-years-old Female with Pancreatic Adenocarcinoma Presenting as Ischemic Enteritis | Carlos Paolo Francisco (Philippines) |
Nov. 30(Sat) 11:00-12:30 |
For the best care of pancreaticobiliary cancers | Skylark (Main 2F) |
Chair(s) | Jun Kyu Lee (Korea), Hee Hyuk Im (Korea) | |
11:00-11:22 | Understanding pancretobiliary cancer | Dongwook Oh (Korea) |
11:22-11:44 | Endoscopic treatment of malignant biliary obstruction | Se Woo Park (Korea) |
11:44-12:06 | Nurse’s role of pancreatobiliary cancers | Mi Soon Kim (Korea) |
12:06-12:28 | Nutrition managements for pancreaticobiliary cancers | MinKyong Yoo (Korea) |
Nov. 30(Sat) |
Controversial issues in liver diseases | Convention Hall C (4F) |
Chair(s) | Kwan Soo Byun (Korea), Han Chu Lee (Korea) | |
13:30-13:50 | NASH Trials: How Far Have We Come? | Jacob George (Australia) |
13:50-14:10 | Non-invasive assessment in cirrhosis or advanced fibrosis | Young Seok Kim (Korea) |
14:10-14:30 | Management of advanced liver disease in elderly patient | Ryosuke Tateishi (Japan) |
Nov. 30(Sat) |
Management of Advanced Liver Diseases | Convention Hall C (4F) |
Chair(s) | Jin Mo Yang (Korea), Naomi Khaing Than Hlaing (Myanmar) | |
14:30-14:50 | Stem cell therapy for cirrhosis | Soon Koo Baik (Korea) |
14:50-15:10 | Recent trend of Liver transplantation | Dong Jin Joo (Korea) |
15:10-15:30 | Emerging therapy of Hepatocellular Carcinoma | Markus Peck (Austria) |
Nov. 30(Sat) |
Presidential Lecture | |
Chair(s) | Dong Soo Han (Korea) | |
14:00-14:40 | Management strategies to improve outcomes of patients with IBD | Joo Sung Kim (Korea) |
Nov. 30(Sat) |
Special Lecture | |
Chair(s) | Joo Sung Kim (Korea) | |
14:40-15:20 | Recent updates of biomarkers in colorectal cancer screening | Joseph J. Y. Sung (Hong Kong) |
Nov. 30(Sat) 14:00-15:30 |
Pancreaticobiliary therapeutic intervention (I) | Emerald Hall A (3F) |
Chair(s) | Myung-Hwan Kim (Korea), Jong Ho Moon (Korea), Hsiu-Po Wang (Taiwan) | |
14:00-14:20 | Biliary Intervention in patients with surgically altered anatomy - EUS-BD or enteroscopy - | Mitsuhiro Kida (Japan) |
14:20-14:40 | EUS guided pancreatic cyst drainage and alcohol ablation | Ji Young Bang (USA) |
14:40-15:00 | EUS-guided gallbladder drainage: technical review and future prospects | Takeshi Ogura (Japan) |
15:00-15:20 | EUS-guided radiofrequency and fiducial placement | Rungsun Rerknimitr (Thailand) |
15:20-15:30 | Discussion |
Nov. 30(Sat) 14:00-15:30 |
Holistic approach for management of obesity and metabolic syndrome: exercies, diet, life style modification, phamacologic tx | Emerald Hall B (3F) |
Chair(s) | Kyu Rae Lee (Korea), Yong-Jin Kim (Korea) | |
14:00-14:25 | Non-pharmacological approach: life style modification, exercise and diet | Byoung-Duck Han (Korea) |
14:25-14:50 | Psychologic issues and intervention | Mirihae Kim (Korea) |
14:50-15:15 | Pharmacological treatment: An up-to-date | Kyoung-Kon Kim (Korea) |
15:15-15:30 | Panel discussion |
Nov. 30(Sat) 14:00-15:30 |
Controversial issues for management of advanced rectal rectal cancer | Diamond Hall (3F) |
Chair(s) | Jonghoon Lee (Korea), Jun Won Um (Korea) | |
14:00-14:22 | Preoperative stenting for left-sided obstructive disease: Should it be reserved for high risk group alone? | Jae Jun Park (Korea) |
14:22-14:44 | Optimal use of rectal radiation therapy for potentially resectable metastatic disease | Ji Ho Nam (Korea) |
14:44-15:06 | Timing of curative surgery for metastatic disease: when should we consult to surgeon? | Jin Yong Shin (Korea) |
15:06-15:28 | Recent advance of preoperative/postoperative systemic therapy | Suk-young Lee (Korea) |
Nov. 30(Sat) |
Grand Ballroom A (Main 2F) | |
Chair(s) | Sam Ryong Jee (Korea), Kyung SiK Park (Korea) | |
14:00-14:10 | Metabolically Healthy Obesity and the Risk of Erosive Esophagitis: A Cohort Study | Tae Jun Kim (Korea) |
14:10-14:20 | Alterations of mucosal impedance values in the duodenum and antrum of patients with functional dyspepsia | Kil Ho Lee (Korea) |
14:20-14:30 | The predictive factors of favorable outcomes in biofeedback therapy in defecatory dysfunction and fecal incontinence patients: real world experience | Jihye Park (Korea) |
14:30-14:40 | Initial Experience And Clinical Outcomes Of Peroral Endoscopic Myotomy For The Treatment Of Esophageal Achalasia And Esophageal Motility Disorders | Kyoungwon Jung (Korea) |
14:40-14:50 | An altered composition of gut microbiota, organic acids, and the effect of probiotics in the guinea pig model of postoperative ileus | Seung Yong Shin (Korea) |
Nov. 30(Sat) 14:00-15:30 |
Advanced nursing in GI cancer | Skylark (Main 2F) |
Chair(s) | Chan-Guk Park (Korea), Jun Kyu Lee (Korea) | |
14:00-14:22 | Oncology emmergencies in GI cancer | Chung Eun Lee (Korea) |
14:22-14:44 | Pain and nursing of GI dancer patients on chemotherapy | Boyoung Byun (Korea) |
14:44-15:06 | Patient safety and nursing of GI cancer patient on chemotherapy | Geun Suk Lee (Korea) |
15:06-15:28 | Social and emotional health and nursing of GI cancer patients on chemotherapy | Eun Ju Park (Korea) |
Nov. 30(Sat) 16:00-17:30 |
Treating acute pancreatitis; what's next? | Convention Hall A (4F) |
Chair(s) | Yong-Tae Kim (Korea), Young Deok Cho (Korea) | |
16:00-16:22 | Etiology and diagnosis, severity classification | Jun Kyu Lee (Korea) |
16:22-16:44 | Optimal medical management | Rungsun Rerknimitr (Thailand) |
16:44-17:06 | Optimal Endoscopic management | Ji Young Bang (USA) |
17:06-17:28 | Surveillence | Se Woo Park (Korea) |
Nov. 30(Sat) |
Convention Hall B (4F) | |
Chair(s) | Geun Am Song (Korea), Hyun-Soo Kim (Korea) | |
16:00-16:10 | Incidence and risk factors of micronutrient deficiency in the patients with inflammatory bowel disease in Korea: folate, vitamin B12, 25-OH-vitamin D, ferritin | Yong Eun Park (Korea) |
16:10-16:20 | Treatment of Ulcerative Colitis with Tonsil-derived Mesenchymal Stem Cells (T-MSCs) via Regulation of Programmed Death-1/Programmed Death Ligand-1 (PD-1/PD-L1) | Eun Mi Song (Korea) |
16:20-16:30 | Metagenomic biomarker for upper gastrointestinal tract involvement in patients with Crohn's disease | Min Seob Kwak (Korea) |
16:30-16:40 | Changes of fecal calprotectin and related clinical factor in neonates | Ji Sook Park (Korea) |
16:40-16:50 | Mechanisms of TL1A promoting epithelial-mesenchymal transition in chronic colitis-associated intestinal fibrosis | Wenxiu Jia (China) |
Nov. 30(Sat) |
Convention Hall B (4F) | |
Chair(s) | Jeong-Sik Byeon (Korea), Dong Il Park (Korea) | |
16:50-17:00 | The Efficacy and Safety of Adalimumab for Patients with Moderately to Severely Active Ulcerative Colitis and Predictors of Response in Korea | Seung Yong Shin (Korea) |
17:00-17:10 | Differentially abundant bacterial taxa associated with progression of Crohn's disease: results from the IMPACT study | Soo-Kyung Park (Korea) |
17:10-17:20 | Novel candidate drug in anti-tumor necrosis factor refractory Crohns diseases: In silico study for drug repositioning | Sara Jeong (Korea) |
17:20-17:30 | Dysbiosis before fecal microbiota transplantation is a positive predictor for a favorable outcome in ulcerative colitis patients | Sowon Park (Korea) |
17:30-17:40 | Molecular Mapping for Dissecting Colorectal Cancer Heterogeneity by MALDI Imaging | Pey Yee Lee (Malaysia) |
Nov. 30(Sat) 16:00-17:30 |
Global trend of SOC based on Guideline | Convention Hall C (4F) |
Chair(s) | Henry LY Chan (Hong Kong), Kwan Sik Lee (Korea), Seung Kew Yoon (Korea) | |
16:00-16:15 | Hepatitis B | Hyung Joon Yim (Korea) |
16:15-16:30 | Hepatitis C | Sang Hoon Ahn (Korea) |
16:30-16:45 | NAFLD and NASH | Henry LY Chan (Hong Kong) |
16:45-17:00 | Alcoholic liver disease | Dong Joon Kim (Korea) |
17:00-17:15 | Autoimmune liver disease | |
17:15-17:30 | Hepatocellular carcinoma | Ji Hoon Kim (Korea) |
Nov. 30(Sat) 16:00-17:30 |
Pancreaticobiliary therapeutic intervention (II) | Emerald Hall A (3F) |
Chair(s) | Sung Koo Lee (Korea), Don Haeng Lee (Korea), Sundeep Lakhtakia (India) | |
16:00-16:25 | RFA for CBD cancer | Jae Hee Cho (Korea) |
16:25-16:50 | Stent in stent for perihilar cholangiocarcinoma | Tae Hoon Lee (Korea) |
16:50-17:15 | Endoscopic techniques for post-endoscopic biliary sphincterotomy bleeding | Sundeep Lakhtakia (India) |
17:15-17:30 | Discussion |
Nov. 30(Sat) 16:00-17:30 |
Endoscopic and surgical intervention for obesity | Emerald Hall B (3F) |
Chair(s) | Seungho Choi (Korea), Roman Turro Arau (Spain) | |
16:00-16:22 | History, indication and reimbursement issue | Sung IL Choi (Korea) |
16:22-16:44 | Preliminary results with the gastric endoscopic sleeve plication (GESP) | Roman Turro Arau (Spain) |
16:44-17:06 | Surgical management of obesity- Bariatric surgery to metabolic surgery | Yong-Jin Kim (Korea) |
Nov. 30(Sat) 16:00-17:30 |
Solving 10 most frequently asked questions from FGID patients in the clinic | Diamond Hall (3F) |
Chair(s) | Soo Teik Lee (Korea), Poong-Lyul Rhee (Korea) | |
16:00-16:22 | Gastroesophageal reflux disease (GERD) | Jie-Hyun Kim (Korea) |
16:22-16:44 | Functional dyspepsia | Joong Goo Kwon (Korea) |
16:44-17:06 | Irritable bowel syndrome | Jeong Hwan Kim (Korea) |
17:06-17:28 | Chronic constipation | Jeong Eun Shin (Korea) |
Nov. 30(Sat) |
Grand Ballroom A (Main 2F) | |
Chair(s) | Moo-In Park (Korea), Hee Seok Moon (Korea) | |
16:00-16:10 | Clinical characteristics in young-age onset colorectal cancer | Subum Park (Korea) |
16:10-16:20 | Tolerability of adjuvant chemotherapy with TS-1 or XELOX regimen in elderly patients with stage II or III gastric cancer after D2 gastrectomy | Min Ji Cho (Korea) |
16:20-16:30 | Acute cardiac toxicity in concurrent chemoradiotherapy for oesophageal cancer | Theingi Htwe (Myanmar) |
16:30-16:40 | Hepatoid Adenocarcinoma Of Gastrointestinal Tract: Experience Of 23 Cases At A Single Tertiary-Care Oncology Centre | Munita Bal (India) |
16:40-16:50 | Optimal adjuvant therapy in patients with locally advanced pancreatic cancer who have received preoperative FOLFIRINOX | Min Kyu Kim (Korea) |
16:50-17:00 | Predictive factors for technical/clinical success of colorectal stenting in malignant colorectal obstruction | Ki-Hyun Kim (Korea) |